|
|
Study: Diabetes drug fails to slow artery buildup
NEW ORLEANS - The controversial diabetes pill Avandia failed to significantly slow plaque buildup in heart arteries compared with an older drug, though there were some hopeful signs in a new study reported Wednesday.
Nations:U.S. U.K. Source:(AP)
2008-11-13
Crestor Study Will Boost Statin Demand
In a study that will likely change medical practice, researchers reported that Crestor, a cholesterol-fighting statin made by AstraZeneca (NYSE:AZN - News), reduced the risk of heart attack, stroke, and cardiovascular disease by a surprisingly robust 45% in people who do not have high cholesterol. The patients did have high levels of a protein associated with arterial inflammation that is not routinely measured.
Nations:Australia Source:(BusinessWeek)
2008-11-10
Despite failures, search for anti-obesity drugs still looks golden
PARIS (AFP) - Designers of anti-obesity drugs have suffered three major setbacks, but the potential reward from treating the world's fat epidemic is so great that their quest is unlikely to be deterred.
Nations:Denmark France Source:(AFP)
2008-11-09
Study: Wider cholesterol drug use may save lives
NEW ORLEANS - People with low cholesterol and no big risk for heart disease dramatically lowered their chances of dying or having a heart attack if they took the cholesterol pill Crestor, a large study found.
2008-11-09
Diabetes drug costs soaring, top $12B last year
CHICAGO - Americans with diabetes nearly doubled their spending on drugs for the disease in just six years, with the bill last year climbing to an eye-popping $12.5 billion.
2008-10-29
| Headlines |
|
Matches Shown: | 1-50 | 51-100
|
|
|
Orencia
